Ross Muken
Stock Analyst at Evercore ISI Group
(1.88)
# 3,142
Out of 5,154 analysts
49
Total ratings
53.57%
Success rate
-0.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $260 → $200 | $174.46 | +14.64% | 11 | Feb 19, 2026 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $77.60 | -9.79% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $107.20 | +123.88% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $115.07 | +12.97% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $44.55 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $217.78 | -69.24% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $124.62 | +100.61% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $501.97 | -56.17% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $8.01 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Feb 19, 2026
Maintains: Outperform
Price Target: $260 → $200
Current: $174.46
Upside: +14.64%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $77.60
Upside: -9.79%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $107.20
Upside: +123.88%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $115.07
Upside: +12.97%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $44.55
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $217.78
Upside: -69.24%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $124.62
Upside: +100.61%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $501.97
Upside: -56.17%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $8.01
Upside: -